Enterin
Biotechnology Research • 
Philadelphia, Pennsylvania, United States • 11-20 Employees
Company overview
| Headquarters | Philadelphia, Pennsylvania, United States |
| Phone number | +12153728031 |
| Website | |
| SIC | 283 |
| Keywords | Parkinson’S Disease, Neurodegenerative Disease, Enteric Nerve System, Gut-Brain Axis, Ent-01 |
| Founded | 2016 |
| Employees | 11-20 |
| Socials |
Key Contacts at Enterin
Michael Zasloff
Founder, Chairman And Ceo
Lisa Bruno
Senior Director Of Clinical Operations
Roger Mills
Member Board Of Directors
Michael Zasloff
Ceo
Enterin Email Formats
Enterin uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About Enterin
Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. We are pioneering the medical community’s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha-synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson’s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson’s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis and improve quality of life of patients with Parkinson’s Disease and other neurodegenerative conditions.
Enterin revenue & valuation
| Annual revenue | $1,400,000 |
| Revenue per employee | $88,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,500,000 |
| Total funding | $16,200,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Enterin has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
Explore Enterin's funding history, including investment rounds, total capital raised, and key backers.
Enterin Tech Stack
Discover the technologies and tools that power Enterin's digital infrastructure, from frameworks to analytics platforms.
Performance
Web servers
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
Video players
UI frameworks
Analytics
SEO
Tag managers
Australia
Israel
South Africa
Frequently asked questions
4.8
40,000 users
